 Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > China factory quality peptide Retatrutide 20mg 30mg 40mg 50mg 60mg lyophilized powder in stock

China factory quality peptide Retatrutide 20mg 30mg 40mg 50mg 60mg lyophilized powder in stock buy - large image1

China factory quality peptide Retatrutide 20mg 30mg 40mg 50mg 60mg lyophilized powder in stock buy - image1

China factory quality peptide Retatrutide 20mg 30mg 40mg 50mg 60mg lyophilized powder in stock

Name: China factory quality peptide Retatrutide 20mg 30mg 40mg 50mg 60mg lyophilized powder in stock
Brand: boruimei
SKU: pr2606082018
Price: 45 USD
Availability: OutOfStock

TDS 7503 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2381089-83-2

Grade:

Laboratory Grade

Content:

99%

Port:

shenzhen

Brand:

boruimei

Packaging:

5mg-60mg*10vials

Price valid (until):

2026-07-08

 The product will be displayed normally on the website later.

Boruimei

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Polypeptide Products

 Visit Store

Product Details
Seller Information
Inquiry History

Description

Name:Alex

Telegram:+852 5603 8853

Whatsapp:+852 5603 8853

Email Address:xu.wenxuan@boruimei.com

Items	Specifications
Product Name:	Retatrutide
CAS:	2381089-83-2
Purity	99%
Shelf life:	24 months
Specification:	10mg/vial 10vials /box
Appearance:	Lyophilized powder

Product Features

High Purity:The purity is ≥99% (HPLC), single impurity ≤0.1%, complies with research quality standards, COA certificate available to guarantee stable and reliable quality.
Stable Performance: Adopts lyophilized powder form with great stability, easy storage and transportation, effectively retains original biological activity.
Clear Mechanism:Triple agonist acting on GLP-1, GIP and GCGR receptors, extensively used in weight control and blood sugar adjustment research.

Product Features

High Purity:The purity is ≥99% (HPLC), single impurity ≤0.1%, complies with research quality standards, COA certificate available to guarantee stable and reliable quality.
Stable Performance:Adopts lyophilized powder form with great stability, easy storage and transportation, effectively retains original biological activity.
Clear Mechanism:Triple agonist acting on GLP-1, GIP and GCGR receptors, extensively used in weight control and blood sugar adjustment research.

1.High quality products with competitive pricing.
2.Free samples available for your evaluation and testing.
3.Fast, reliable delivery via reputable shipping lines.
4.Trial orders are welcome for quality verification after sample approval.
5.Proactive updates and full transparency at every stage of your order.
6.Custom packaging solutions tailored to meet your specific requirements.

Our factory

How to order

Delivery time

• USA: 7-12days (tax included)

• Europe: 7–12 days (tax included)

• Australia: 7–12 days (tax included)

• Canada: 7–12 days (tax included)

• Asia and Southeast Asia: 5–10 days (tax included)

• Free redelivery is available if the parcel fails to arrive on time.

FAQ

1.Can we get your free samples?

Yes, can. Our free sample can be provided for customers test. But the freight for express is obuyer's account.

2.Can we do printing or label on the bottles?

Yes, can. We can offer various printing ways,such, screen printing, hot stamping, label printing.

3.What is the normal lead time?

For stock products, within 24-48 hours after we receive your payment. For smaller customize color bottles, we will ship out within 3-5 days.

4.What is your shipping terms?

Faster ways: FEDEX, DHL, UPS, TNT, etc by sea or by air economy

5.How does your factory do regarding quality control?

We do test for 3 times before packing.

ECHEMI Editorial Reference

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

Certificates

Basic Info

Product Name:

Retatrutide

Other Name:

Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

CAS No.:

2381089-83-2

InChIKeys:

MLOLQJNKXBNWFW-SAGGEDDASA-N

Molecular Weight:

EC Number:

200-001-8

Color/Form:

White lyophilized

Categories:

Polypeptide

Characteristics

Water Solubility:

Soluble in water (5mg/ml).

Storage Conditions:

-20°C

Critical Temperature & Pressure:

-20°C

Research

Class:

Triple agonist — GCGR, GIPR, GLP-1R

Status:

Investigational (Phase 3)

Mechanism:

Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

EC50 (Human GCGR):

5.79 nM

EC50 (Mouse GIPR):

0.191 nM

EC50 (Mouse GLP1R):

0.794 nM

EC50 (Mouse GCGR):

2.32 nM

EC50 (Human GLP1R):

0.775 nM

EC50 (Human GIPR):

0.0643 nM

Source:

Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

Clinical Development:

NCT04881760; NCT05882045; NCT06354660

References

ChEMBL:

DrugBank:

KEGG DRUG:

PubChem:

Literature:

NEJM: Jastreboff et al. (2023) — Phase 2 Trial; FDA Drugs@FDA

Disclaimer:

Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

See More Retatrutide Properties 

Seller Information

Business Type:
Trader

Main Products:
Polypeptide Products

Location:
No. 917, 9th Floor, Unit 1, Building 19, Shengshi Huayuan Business Center, Shunhua Road Sub-district, High-tech Zone, Jinan City, Shandong Province

Total Annual Revenue:
Less than $1 million

Total Employees:
5-10

Year of Establishment:
2026

Inquiry History

7503 Inquiries

Country	Product	Purchase Quantity	Date Posted
Malaysia	Retatrutide	20 MG	Oct 28, 2026
Australia	Retaturtide	100 MG	Oct 29, 2026
United States	Retatrutide 30mg and 50mg	20 PCS	Oct 29, 2026
Belgium	Retatrutide	1 MG	Oct 29, 2026
Romania	Retatrutide	10 G	Oct 29, 2026
United States	Retatrutide	2 MT	Oct 29, 2026
United States	Retatrutide	1 MT	Oct 29, 2026
United Kingdom	Retatrutide	1 PCS	Oct 28, 2026
United States	Retatrutide	30 MT	Oct 28, 2026
United Kingdom	Retatrutide	10 MT	Oct 28, 2026
United States	retatrutide	30 MG	Oct 28, 2026
Czech	Retatrutide	10 MG	Oct 28, 2026
Austria	retatrutide	30 MG	Oct 28, 2026
United States	Retatrutide	100 KG	Oct 28, 2026
Malta	Retatrutide	10 MT	Oct 28, 2026
United States	Retatrutide	600 MG	Oct 28, 2026
United States	Retatrutide	500 G	Oct 28, 2026
United States	Retatrutide	60 G	Oct 28, 2026
Croatia	Retatrutide	10 MG	Oct 28, 2026
United States	Retatrutide	200 MG	Oct 28, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Semax Peptide CAS 80714-61-0 5mg 10 Vials Lyophilized Powder Research Grade USD 45	Pharmaceutical Grade/99	$45/MT FOB	Guangzhou Chunqiao Trading Co., Ltd.	Inquiry
Retatrutide, LY3437943	Reagent Grade/99	$200-250/G FOB	cellmano peptide	Inquiry
Retatrutide Lyophilized API Powder Bulk Wholesale Raw Material	Pharmacy Grade/95	$120-150/G FOB	XIUSHI BIOPHARMA (NANTONG) CO., LTD.	Inquiry
Factory 99% Purity Weight Loss Peptide GLP-1 Retatrutide cas 2381089-83-2	Pharmaceutical Grade/99	$103/UNIT FOB	Beijing Novio Biotechnology Co., Ltd.	Inquiry
Dependable peptide supplies for research lab trials, reliable assay outcomes, customizable packing selections	Research Grade/99	$60/UNIT EXW	Jiangsu Lilly Bio	Inquiry

China factory quality peptide Retatrutide 20mg 30mg 40mg 50mg 60mg lyophilized powder in stock

Product Details

Seller Information

Inquiry History

Product Features

Product Features

More Choices Find All Products for Sale 

Related Searches

More from this Seller